Clinical implications of TMPRSS2-ERG gene fusion expression in patients with prostate cancer treated with radical prostatectomy.
Rubio-Briones
José
J
Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
Fernández-Serra
Antonio
A
Calatrava
Ana
A
García-Casado
Zaida
Z
Rubio
Luis
L
Bonillo
Miguel A
MA
Iborra
Inmaculada
I
Solsona
Eduardo
E
López-Guerrero
José A
JA
D000368:Aged; D000369:Aged, 80 and over; D018450:Disease Progression; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D050939:Gene Fusion; D006801:Humans; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011379:Prognosis; D016016:Proportional Hazards Models; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000601:surgery*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D015514:Oncogene Proteins, Fusion; C515553:TMPRSS2-ERG fusion protein, human